Prosecution Insights
Last updated: April 19, 2026

Examiner: CHANG, KYUNG SOOK

Tech Center 3700 • Art Units: 1613 1617 1672 3786

This examiner grants 61% of resolved cases

Performance Statistics

60.7%
Allow Rate
-9.3% vs TC avg
850
Total Applications
+40.7%
Interview Lift
1020
Avg Prosecution Days
Based on 786 resolved cases, 2023–2026

Rejection Statute Breakdown

2.2%
§101 Eligibility
9.0%
§102 Novelty
45.8%
§103 Obviousness
21.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18577720 TABLET COMPRISING A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID Non-Final OA Novo Nordisk A/S
18276936 HYDROGEL MATERIALS AND METHODS OF MAKING AND TRANSPORT USING THE SAME Non-Final OA Georgia Tech Research Corporation
18528125 MICROLAYER COEXTRUSION TO CREATE A TIME-RELEASE DRUG SUBSTANCE DELIVERY PRODUCT Non-Final OA Guill Tool & Engineering Co., Inc.
18681600 COMPOSITION FOR GENERATING NITROGEN MONOXIDE Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18378720 BUFFERED ADHESIVE COMPOSITIONS FOR SKIN-ADHERING MEDICAL PRODUCTS Non-Final OA HOLLISTER INCORPORATED
17593514 MOUSSE PRODUCTS, METHODS AND DEVICES Non-Final OA Honeywell International Inc.
18595636 COSMETIC Non-Final OA SHIN-ETSU CHEMICAL CO., LTD.
18686228 COMPOSITION FOR REGENERATING MASTOID BONE USING IN VIVO ONE-STEP STEM CELL DIFFERENTIATION Non-Final OA AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
17784598 SYNTHETIC TISSUE BARRIERS AND USES THEREOF Non-Final OA The Brigham and Women's Hospital, Inc.
18673481 BIOCOMPATIBLE MATERIAL AND METHODS FOR MAKING AND USING THEREOF Non-Final OA The Hong Kong University of Science and Technology
17285743 Bioadhesive for Soft Tissue Repair Final Rejection Northeastern University
18259836 STABLE EFFICIENT COSMETIC PREPARATIONS Non-Final OA YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
18265867 AN ANTIPERSPIRANT COMPOSITION Final Rejection Conopco, Inc., d/b/a UNILEVER
18037359 TOPICAL SANITISING COMPOSITION COMPRISING MINIMAL AMOUNTS OF AN ANTIMICROBIAL LIPID Final Rejection Conopco, Inc., d/b/a UNILEVER
18702383 COMPOSITION COMPRISING GELATIN, GELATIN FILMS AND CAPSULES Non-Final OA Tessenderlo Group NV
18597717 ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS Non-Final OA Jazz Pharmaceuticals Research UK Limited
18681812 AN IMPROVED PROCESS FOR THE PREPARATION OF AN AQUEOUS OPHTHALMIC SOLUTION OF DIFLUPREDNATE Non-Final OA SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
18528153 ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION Non-Final OA Flurry Powders, LLC
18564563 PAIN RELIEF PATCH Non-Final OA CS MEDICA A/S
18156058 Phosphorylated Tri-Block Copolymers with Anti-Microbial Properties Non-Final OA UChicago Argonne, LLC
17919955 TREATMENT REGIMEN WITH MINOXIDIL AND CAFFEINE Non-Final OA Dr. Kurt Wolff GmbH & Co. KG
18285645 FORMULATION AND METHOD FOR TREATMENT OF URINARY SYSTEM DISORDERS Non-Final OA WATERSHED MEDICAL INC
18553657 A NANOFORMULATION FOR GLIOMA TREATMENT AND PROCESS FOR ITS PREPARATION THEREOF Non-Final OA JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
18467857 ORAL SOFT GEL CAPSULE CONTAINING PSYCHEDELIC COMPOUND Non-Final OA Avenir Wellness Solutions, Inc.
18549330 PULLULAN CAPSULES Final Rejection Capsugel Belgium NV
17920346 HPMC CAPSULE WITH REDUCED POWDER RETENTION Final Rejection Capsugel Belgium NV
18279916 GRANULES CONTAINING AN ACTIVE SUBSTANCE, METHOD FOR PREPARING SAME AND USE THEREOF IN FOOD FOR HUMAN CONSUMPTION OR ANIMAL FEED Non-Final OA CAPSULAE
18276540 Pectin Compositions and Methods of Use Non-Final OA The Brigham and Women`s Hospital, Inc.
18275214 MEDICAL TISSUE ADHESIVE AND PREPARATION METHOD THEREOF Non-Final OA HAINING ZHULUOJI BIOTECHNOLOGY CO., LTD.
17910329 CONTROLLED RELEASE FORMULATIONS COMPRISING DROTAVERINE OR SALT THEREOF Final Rejection Sushma Paul BERLIA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month